SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-000930
Filing Date
2018-04-05
Accepted
2018-04-05 12:07:40
Documents
32
Period of Report
2018-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannabics_10q-022818.htm 10-Q 407053
2 CERTIFICATION cannabics_10q-3101.htm EX-31.1 11171
3 CERTIFICATION cannabics_10q-3102.htm EX-31.2 11181
4 CERTIFICATION cannabics_10q-3201.htm EX-32.1 5457
5 CERTIFICATION cannabics_10q-3202.htm EX-32.2 5373
6 GRAPHIC image_001.jpg GRAPHIC 139432
7 GRAPHIC image_002.jpg GRAPHIC 252846
  Complete submission text file 0001683168-18-000930.txt   1582826

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE cnbx-20180228.xml EX-101.INS 68322
9 XBRL SCHEMA FILE cnbx-20180228.xsd EX-101.SCH 9647
10 XBRL CALCULATION FILE cnbx-20180228_cal.xml EX-101.CAL 24354
11 XBRL DEFINITION FILE cnbx-20180228_def.xml EX-101.DEF 13288
12 XBRL LABEL FILE cnbx-20180228_lab.xml EX-101.LAB 81448
13 XBRL PRESENTATION FILE cnbx-20180228_pre.xml EX-101.PRE 59526
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 18739839
SIC: 2834 Pharmaceutical Preparations